KZIA Kazia Therapeutics Limited - American Depositary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ 10-K/10-Q Nov 7, 2025
$8.33
· of 52w range
· above low
· to high
$4.9152w low
$17.4052w high
P/E
-165.9
EPS
$-0.04
Revenue
$42.0K
your badges
52W Range
$5–$17
Analyst Rating
BUY
Price Target
$30
P/E
-165.9
ROE
226.0%
Net Profit Margin
-49290.5%
Your badge strip is empty — pin a metric anywhere on this page.
KZIA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.33
P/E
-165.9
EPS
$-0.04
Revenue
$42.0K
ROE
226.0%
52W Range
$5–$17
KZIA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| April 17, 2025 | 1-for-5 | Reverse |
| Oct. 28, 2024 | 1-for-10 | Reverse |
| July 14, 2017 | 1-for-4 | Reverse |
| Jan. 28, 2013 | 1519-for-500 | Forward |
| Jan. 3, 2012 | 1-for-5 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$42.0K2017-06-30 → 2025-06-30
EPS$-0.042017-06-30 → 2025-06-30
Net margin-49290.5%2018-06-30 → 2025-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | KZIA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -165.95Y avg ≈-477.0 | ≈-477.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | KZIA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Pretax Margin | -53447.6% | · | · | · | |
| Net Profit Margin | -49290.5% | · | · | · | |
| ROA | -149.8%5Y avg ≈-93.8% | ≈-93.8% | · | · | |
| ROE | 226.0%5Y avg ≈-657.6% | ≈-657.6% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | KZIA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 0.45Y avg ≈0.9 | ≈0.9 | · | · | |
| Quick Ratio | 0.35Y avg ≈0.8 | ≈0.8 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | KZIA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | |
| Receivables Turnover | 0.0 | · | · | · | |
| Revenue / Employee | ≈$7.0K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-186.5%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Dec. 31, 2025 | $-0.81 | $-0.33 | -142.8% | |
| June 30, 2025 | $1.42 | $-1.33 | 207.1% | |
| Dec. 31, 2024 | $-12.30 | $-17.44 | 29.5% | |
| June 30, 2023 | $-9.50 | $-2.55 | -272.5% | |
| June 30, 2022 | $-43.55 | $-5.10 | -753.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42.0K | $2M | $0 | · | · | · | · | $119.0K | $249.0K | |
| R&D Expense | $7M | $17M | $16M | $20M | $15M | $9M | $6M | $10M | $11M | |
| SG&A Expense | $9M | $14M | $9M | $5M | $7M | $4M | $4M | $6M | $9M | |
| Interest Expense | · | · | · | · | · | · | · | $0 | $1.0K | |
| Interest Income | $72.0K | $12.0K | $22.0K | $2.0K | $42.0K | $66.0K | $100.0K | $119.0K | $249.0K | |
| Pretax Income | $-22M | $-27M | $-21M | $-25M | $-9M | $-13M | $-11M | $-6M | $-11M | |
| Income Tax | $-2M | $-271.0K | $-271.0K | $-368.0K | $-484.0K | $-298.0K | $-298.0K | $-305.0K | $-199.0K | |
| Net Income | $-21M | $-27M | $-20M | $-25M | $-8M | $-12M | $-10M | $-6M | $-11M | |
| EPS (Basic) | $-0.04 | $-0.10 | $-0.11 | $-0.19 | $-0.07 | $-0.17 | $-17.86 | $-12.48 | $-2.28 | |
| EPS (Diluted) | $-0.04 | $-0.10 | $-0.11 | $-0.19 | $-0.07 | $-0.17 | $-17.86 | $-12.48 | $-2.28 | |
| Shares (Basic) | · | · | 184,284,350 | 132,467,686 | 117,674,543 | 73,053,514 | 57,503,555 | 48,376,525 | 467,833,849 | |
| Shares (Diluted) | 547,941,171 | 263,676,313 | 184,284,350 | 132,467,686 | 117,674,543 | 73,053,514 | 57,503,555 | 48,376,525 | 467,833,849 | |
| EBITDA | · | · | · | · | · | $1M | $1M | $2M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $2M | $5M | $7M | $21M | $1M | $834.0K | $3M | $8M | |
| Receivables | $98.0K | $4M | $4M | $91.0K | $84.0K | $1M | $2M | $3M | $4M | |
| Current Assets | $5M | $6M | $11M | $9M | $29M | $11M | $8M | $9M | $19M | |
| PP&E (Net) | · | · | · | · | · | · | · | $1.0K | $490.0K | |
| Intangibles | $1M | $15M | $17M | $19M | $21M | $12M | $13M | $15M | $16M | |
| Total Assets | $6M | $22M | $28M | $36M | $58M | $23M | $21M | $28M | $36M | |
| Accounts Payable | $10M | $15M | $4M | $4M | $5M | $3M | $2M | $2M | $2M | |
| Current Liabilities | $14M | $26M | $8M | $7M | $8M | $5M | $2M | $4M | $5M | |
| Total Liabilities | $14M | $32M | $16M | $18M | $20M | $9M | $7M | $9M | $11M | |
| Retained Earnings | $-135M | $-115M | $-89M | $-69M | $-44M | $-36M | $-25M | $-15M | $-171M | |
| Stockholders' Equity | $-8M | $-10M | $12M | $18M | $38M | $14M | $14M | $19M | $25M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $1M | $1M | $2M | $1M | |
| Other Non-cash | · | · | · | · | · | $3M | $2M | $-4M | · | |
| Operating Cash Flow | $-13M | $-10M | $-15M | $-23M | $-9M | $-9M | $-7M | $-9M | $-11M | |
| CapEx | · | · | · | · | · | · | · | · | $12.0K | |
| Investing Cash Flow | · | $0 | $0 | $-2M | · | · | $2M | $150.0K | $-7M | |
| Financing Cash Flow | $16M | $6M | $13M | $4M | $28M | $12M | $4M | · | $-18.0K |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -49290.5% | · | · | · | · | · | · | -5074.8% | · | |
| Pretax Margin | -53447.6% | · | · | · | · | · | · | -5331.1% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | 1300.0% | · | |
| ROA | -149.8% | -107.8% | -64.0% | -53.5% | -20.8% | -56.4% | -41.6% | -18.9% | · | |
| ROE | 226.0% | -2634.3% | -135.0% | -87.3% | -32.4% | -88.0% | -61.4% | -27.1% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | 0.2 | 1.4 | 1.6 | 3.5 | 2.1 | 4.0 | 2.4 | · | |
| Quick Ratio | 0.3 | 0.2 | 1.2 | 1.6 | 2.5 | 0.5 | 1.3 | 1.4 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | 0.0 | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.00 | · | · | · | · | · | · | $0.00 | · | |
| Cash Flow / Share | $-0.02 | · | $-0.08 | $-0.17 | $-0.08 | $-0.12 | $-0.12 | $-0.18 | · | |
| EPS (TTM) | $-0.04 | $-0.10 | $-0.11 | $-0.19 | $-0.07 | $-0.17 | $-17.86 | $-12.48 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42.0K | $2M | $0 | · | · | · | · | $119.0K | · | |
| Net Income TTM | $-21M | $-27M | $-20M | $-25M | $-8M | $-12M | $-10M | $-6M | · | |
| P/E | -165.9 | -113.2 | -516.5 | -1112.3 | -6885.5 | -993.0 | -7.3 | -11.9 | · | |
| Earnings Yield | -0.60% | -0.88% | -0.19% | -0.09% | -0.01% | -0.10% | -13.7% | -8.4% | · |
Per Share
| Metric | Trend | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 | Q4 2009 | Q4 2008 | Q4 2007 | Q4 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-2.28 | $-2.82 | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 | Q4 2009 | Q4 2008 | Q4 2007 | Q4 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $249.0K | $406.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-11M | $-12M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -78.9 | -132.6 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.3% | -0.75% | · | · | · | · | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-07-01 |
|---|---|---|---|---|---|
| Revenue | $42.0K | $2M | $0 | · | · |
| Net Income | $-21M | $-27M | $-20M | $-25M | · |
| Diluted EPS | $-0.04 | $-0.10 | $-0.11 | $-0.19 | · |
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-07-01 |
|---|---|---|---|---|---|
| Current Ratio | 0.4 | 0.2 | 1.4 | 1.6 | · |
| Quick Ratio | 0.3 | 0.2 | 1.2 | 1.6 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 43 filers · $57.0M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
43
Value held
$57.0M
New positions
22
Exited positions
5
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 22 (+15 vs prior Q) | 5 (-1 vs prior Q) | 10 (+3 vs prior Q) | 4 (0 vs prior Q) | +2.3M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Boxer Capital Management, LLC | $7,884,800 | 560,000 | 13.84% | Shares |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $5,842,609 | 414,958 | 10.25% | Shares |
| Bleichroeder LP | $5,632,000 | 400,000 | 9.88% | Shares |
| Ikarian Capital, LLC | $5,578,510 | 396,201 | 9.79% | Shares |
| Dauntless Investment Group, LLC | $4,987,249 | 354,208 | 8.75% | Shares |
| Stonepine Capital Management, LLC | $4,860,120 | 345,179 | 8.53% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,543,936 | 251,700 | 6.22% | Call option |
| Point72 Asset Management, L.P. | $2,304,224 | 200,300 | 4.04% | Shares |
| Ensign Peak Advisors, Inc | $1,559,754 | 110,778 | 2.74% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,427,374 | 101,376 | 2.50% | Shares |
| UBS Group AG | $1,141,748 | 81,090 | 2.00% | Shares |
| CITADEL ADVISORS LLC | $1,070,080 | 76,000 | 1.88% | Call option |
| J. Goldman & Co LP | $964,353 | 68,491 | 1.69% | Shares |
| ADAR1 Capital Management, LLC | $866,624 | 61,550 | 1.52% | Shares |
| JANE STREET GROUP, LLC | $804,531 | 57,140 | 1.41% | Shares |
| BARCLAYS PLC | $802,546 | 56,999 | 1.41% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $712,673 | 50,616 | 1.25% | Shares |
| COOPERMAN LEON G | $704,000 | 50,000 | 1.24% | Shares |
| Westside Investment Management, Inc. | $669,997 | 47,585 | 1.18% | Shares |
| MORGAN STANLEY | $656,212 | 46,606 | 1.15% | Shares |
| MARSHALL WACE, LLP | $622,772 | 44,231 | 1.09% | Shares |
| SteelPeak Wealth, LLC | $580,709 | 60,522 | 1.02% | Shares |
| JANE STREET GROUP, LLC | $506,880 | 36,000 | 0.89% | Call option |
| XTX Topco Ltd | $439,099 | 31,186 | 0.77% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $430,848 | 30,600 | 0.76% | Put option |
| BNP PARIBAS FINANCIAL MARKETS | $423,667 | 30,090 | 0.74% | Shares |
| CITADEL ADVISORS LLC | $401,407 | 28,509 | 0.70% | Shares |
| RAYMOND JAMES FINANCIAL INC | $318,194 | 22,599 | 0.56% | Shares |
| Sequoia Financial Advisors, LLC | $281,643 | 20,003 | 0.49% | Shares |
| Engineers Gate Manager LP | $210,848 | 14,975 | 0.37% | Shares |
| Laird Norton Wetherby Trust Company, LLC | $181,632 | 12,900 | 0.32% | Shares |
| UNITED BANK | $180,941 | 12,851 | 0.32% | Shares |
| Rockefeller Capital Management L.P. | $178,816 | 12,700 | 0.31% | Shares |
| T3 Companies, LLC | $95,950 | 10,000 | 0.17% | Shares |
| JPMORGAN CHASE & CO | $41,399 | 2,863 | 0.07% | Shares |
| GAMMA Investing LLC | $21,723 | 2,264 | 0.04% | Shares |
| RAYMOND JAMES FINANCIAL INC | $20,000 | 2,000 | 0.04% | Call option |
| RHUMBLINE ADVISERS | $18,245 | 1,296 | 0.03% | Shares |
| FNY Investment Advisers, LLC | $12,000 | 1,350 | 0.02% | Shares |
| Arax Advisory Partners | $1,225 | 87 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $338 | 24 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $140 | 10 | 0.00% | Shares |
| Allworth Financial LP | $15 | 1 | 0.00% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| SS. OR ×13 filings | Nov. 25, 2013 | · | Initial filing | · | SEC |
| Novogen Limited (2) ×6 filings | Dec. 7, 2012 | · | Initial filing | M&A / sale | SEC |
| Novogen Limited ×2 filings | May 11, 2011 | · | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person, Undisclosed reporting person | April 4, 2006 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 8 insiders · 5 officers · 3 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| John E. Friend II | Chief Executive Officer | Jan. 8, 2026 A | · | 0 | 0 | $0 |
| James E. Levine | Chief Financial Officer | June 19, 2026 A | · | 0 | 0 | $0 |
| Sudha Rao | Chief Scientific Officer | June 19, 2026 A | · | 0 | 0 | $0 |
| David Cain | Director, CMC | Jan. 8, 2026 A | · | 0 | 0 | $0 |
| Jeffrey Bonacorda | VP, Finance and Controller | Jan. 8, 2026 A | · | 0 | 0 | $0 |
| Ebru Davidson | Director | Jan. 8, 2026 A | · | 0 | 0 | $0 |
| Steven R. S. Coffey | Director | Jan. 8, 2026 A | · | 0 | 0 | $0 |
| Robert F Apple | Director | Jan. 8, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| APIE · Trust for Professional Managers | 0.00% | 3,423 NS | Aug. 31, 2026 | N-PORT |
KZIA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$30.16
+262.1%
3 25.0%
Strong Buy
8 66.7%
Buy
1 8.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
8 analysts · 2026-10-24Mean target $29.60 +255.3%
← Below all targets
Current price $8.33
Low$17.63
Mean$29.60
High$39.52
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Nov 7, 2025